RSPI RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.04    OTCQB
As of 04/13/2021     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  07/18/1989
Outstanding shares:  75,646,039
Average volume:  5,142,953
Market cap:   $3,003,148
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -0.02
PS ratio:   0.00
Return on equity:   53.10%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy